(Q44819667)

English

Impact of early vs late postoperative radioiodine remnant ablation on final outcome in patients with low-risk well-differentiated thyroid cancer

scientific article published on 21 August 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Impact of early vs late postoperative radioiodine remnant ablation on final outcome in patients with low-risk well-differentiated thyroid cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

author name string

Sofia Tsirona

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Varvara Vlassopoulou

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Marinella Tzanela

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Phoebe Rondogianni

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

George Ioannidis

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Charalambos Vassilopoulos

6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Efthimia Botoula

7

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Panagiotis Trivizas

8

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Ioannis Datseris

9

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Stylianos Tsagarakis

10

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

publication date

21 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Clinical Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

80

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

459-463

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

The management of thyroid cancer in adults: a review of new guidelines.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12301

21 January 2018

Use of radioactive iodine for thyroid cancer

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12301

21 January 2018

Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12301

21 January 2018

Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12301

21 January 2018

Invasive well-differentiated thyroid carcinoma: effect of treatment modalities on outcome

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12301

21 January 2018

Differentiated thyroid cancer: management of patients with radioiodine nonresponsive disease

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12301

21 January 2018

Thyroid cancer: a lethal endocrine neoplasm

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12301

21 January 2018

European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12301

21 January 2018

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12301

21 January 2018

Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I : practice recommendations of the American Thyroid Association.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12301

21 January 2018

Delayed initial radioactive iodine therapy resulted in poor survival in patients with metastatic differentiated thyroid carcinoma: a retrospective statistical analysis of 198 cases.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12301

21 January 2018

Clinical features and prognostic factors for survival in patients with poorly differentiated thyroid carcinoma and comparison to the patients with the aggressive variants of papillary thyroid carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12301

21 January 2018

Strategies of radioiodine ablation in patients with low-risk thyroid cancer

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12301

21 January 2018

Clinical review 170: A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12301

21 January 2018

The effectiveness of radioactive iodine for treatment of low-risk thyroid cancer: a systematic analysis of the peer-reviewed literature from 1966 to April 2008.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12301

21 January 2018

Disease severity and radioactive iodine use for thyroid cancer

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12301

21 January 2018

Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12301

21 January 2018

Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12301

21 January 2018

Identifiers

10.1111/CEN.12301

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44819667&oldid=2047838628"